In part one of this series, Dr. Dara Albert and Dr. Bruce Cohen discuss why the Child Neurology Society felt it was important to establish a task force to examine child neurology training at this point in time.

Show citation:

Cohen BH, Gilbert DL, Xixis K, et al. Education Research: The Future of Child Neurology Residency Training: The Perspective of a Child Neurology Society Task Force. Neurol Educ. 2026;5(2):e200331. Published 2026 Jun 12. doi:10.1212/NE9.0000000000200331

In the first part of this two-part series, Dr. Tesha Monteith and Dr. Tamara Pringsheim provide a brief overview of the guideline recommendations for pharmacologic treatment of migraine prevention in adults.

Show citation:

Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society. Headache. Published online August 31, 2026. doi:10.1111/head.70199

In the fifth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses syndrome of subjective doubles.

In the fourth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses mirrored self-misidentification syndrome.

In the third episode of this nine-part series, Dr. Christine Cliatt-Brown discusses Fregoli syndrome.

Dr. Justin Abbatemarco and Dr. Irene Cortese discuss recent advances in the treatment of progressive multifocal leukoencephalopathy (PML), focusing on immune-based therapies like virus-specific T cells and immune checkpoint inhibitors.

Show citation:

Gonzalez CE, Fletcher A, Jenkins TL, et al. Resolution of PML after Treatment with Virus-Specific T Cells and HCT. N Engl J Med. 2026;394(20):2061-2064. doi:10.1056/NEJMc2514186

Dr. Kait Nevel and Drs. Ayal Aizer and Clara Baselga-Garriga discuss the link between primary motor cortex involvement in brain metastases and increased seizure risk.

Show citation:

Baselga-Garriga C, Purohit S, Lamba N, et al. Primary Motor Cortex Involvement and Its Association With Seizure Risk in Patients With Brain Metastases. Neurology. 2026;106(7):e214714. doi:10.1212/WNL.0000000000214714

In part two of this nine-part series, Dr. Christine Cliatt-Brown discusses Capgras syndrome.

In part one of this nine-part series, Dr. Christine Cliatt-Brown provides an overview of delusional misidentification syndromes.

In the final episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the complex role of TNF alpha inhibition in tuberculosis treatment and the use of infliximab and other targeted therapies to manage inflammation.